tiprankstipranks
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
PremiumPress ReleasesOncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
8d ago
OncoCyte, BioRad to partner on global launch of GraftAssure assay
PremiumThe Fly
OncoCyte, BioRad to partner on global launch of GraftAssure assay
8d ago
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
PremiumPress Releases
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
10d ago
OncoCyte begins FDA submissions process for VitaGraft transplant assays
PremiumThe FlyOncoCyte begins FDA submissions process for VitaGraft transplant assays
5M ago
Oncocyte Reports Third Quarter 2023 Financial Results
PremiumPress Releases
Oncocyte Reports Third Quarter 2023 Financial Results
5M ago
OncoCyte reports Q3 EPS (81c), consensus ($1.01)
PremiumThe Fly
OncoCyte reports Q3 EPS (81c), consensus ($1.01)
5M ago
OncoCyte price target lowered to $5 from $9 at Benchmark
PremiumThe FlyOncoCyte price target lowered to $5 from $9 at Benchmark
8M ago
OncoCyte price target lowered to $3.50 from $6 at Piper Sandler
PremiumThe Fly
OncoCyte price target lowered to $3.50 from $6 at Piper Sandler
8M ago
OncoCyte reports Q2 EPS ($1.03), consensus (87c)
PremiumThe Fly
OncoCyte reports Q2 EPS ($1.03), consensus (87c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100